Sign In
Buy EYPT
$12.25
-0.610 (-4.74%)
At Close: Jul 31, 2026
Celcuity (CELC) Gets a Buy Rating from H.C. Wainwright - Markets
10:25am, Tuesday, 23'rd Jun 2020
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Celcuity (CELC – Research Report),
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fate Therapeutics (FATE – Research
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up to $0.88
06:32am, Saturday, 20'th Jun 2020
Shares of Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) gapped up before the market opened on Thursday . The stock had previously closed at $0.88, but opened at $0.88. Eyepoint Pharmaceuticals shares las
HTG Molecular Diagnostics (HTGM) Gets a Buy Rating from H.C. Wainwright - Markets
10:18am, Friday, 19'th Jun 2020
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on HTG Molecular Diagnostics (HTGM –
EyePoint Pharmaceuticals (EYPT) Surges: Stock Moves 7.4% Higher
12:42pm, Thursday, 18'th Jun 2020
EyePoint Pharmaceuticals (EYPT) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Analysts Are Bullish on These Healthcare Stocks: Momenta Pharma (MNTA), Otonomy (OTIC) - Markets
10:08am, Tuesday, 16'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Momenta Pharma
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Global Blood Therapeutics (GBT –
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CytoDyn (CYDY
Analysts Offer Insights on Technology Companies: Iteris (NASDAQ: ITI), Quantum (NASDAQ: QMCO) and OptimizeRx (NASDAQ: OPRX) - Markets
11:36am, Wednesday, 10'th Jun 2020
There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Iteris (ITI
Large caps deny they're being outgunned by smaller peers in health R&D - Stockhead
09:18am, Wednesday, 10'th Jun 2020
The journey of each individual medical treatment from idea to market requires the involvement of multiple parties big and small. The general consensus seems to be that it takes a big player to get a d
Filled jobs fall 0.1 per cent: Aus shares close 0.1% higher
07:08am, Wednesday, 10'th Jun 2020
10 Jun 2020 - The Australian share market fell at the open, but closed 0.1 per cent up at the end of trade. Filled jobs fell by 0.1 per cent and hours worked by 0.8 per cent between the December and M
What's Opthea eyeing now that it has two successful trials under its belt? - Stockhead
03:44am, Wednesday, 10'th Jun 2020
Having now proven its drug works on two eye diseases, Opthea (ASX:OPT) is looking to future treatment options. The immediate consideration for Opthea is a phase three study on Diabetic Macular Edema
Opthea (ASX:OPT) reports positive trial results: Aus shares 0.5% higher at noon
02:49am, Wednesday, 10'th Jun 2020
10 Jun 2020 - The Australian share market opened lower but is now trading 0.5 per cent up at noon. Opthea (ASX:OPT) has reported positive Phase 2a trial results for its OPT-302 treatment in Diabetic M
